Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 500259 | NSE: LYKALABS

139.64
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  142.00
  •  144.00
  •  138.60
  •  141.59
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  60675
  •  85.59
  •  176.59
  •  97.90

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 422.39
  • 102.60
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 454.78
  • N/A
  • 4.16

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 58.10%
  • 4.90%
  • 32.13%
  • FII
  • DII
  • Others
  • 0.15%
  • 0.29%
  • 4.43%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 12.58
  • -16.95

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -31.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -47.18
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.56
  • 6.04
  • 18.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 100.16
  • 55.54
  • 20.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
33.80
32.56
3.81%
41.16
27.99
47.05%
30.11
22.88
31.60%
27.77
22.24
24.87%
Expenses
28.60
25.70
11.28%
36.20
23.81
52.04%
26.41
20.23
30.55%
25.74
18.94
35.90%
EBITDA
5.19
6.86
-24.34%
4.95
4.18
18.42%
3.71
2.64
40.53%
2.03
3.30
-38.48%
EBIDTM
15.37%
21.08%
12.03%
14.94%
12.31%
11.56%
7.31%
14.82%
Other Income
0.83
0.54
53.70%
0.03
0.25
-88.00%
0.56
0.38
47.37%
0.29
0.43
-32.56%
Interest
0.61
1.28
-52.34%
0.54
1.19
-54.62%
0.65
1.35
-51.85%
1.07
2.85
-62.46%
Depreciation
1.83
2.84
-35.56%
1.76
3.60
-51.11%
1.76
3.47
-49.28%
2.90
3.47
-16.43%
PBT
3.57
3.29
8.51%
2.67
-0.79
-
1.86
-1.80
-
-1.63
-3.00
-
Tax
0.87
1.27
-31.50%
0.76
-0.18
-
0.57
0.13
338.46%
0.46
0.00
0
PAT
2.71
2.01
34.83%
1.91
-0.62
-
1.29
-1.93
-
-2.09
-3.00
-
PATM
8.00%
6.18%
4.65%
-2.20%
4.28%
-8.44%
-7.52%
-13.47%
EPS
0.76
0.54
40.74%
0.59
-0.15
-
0.40
-0.56
-
-0.64
-0.98
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Net Sales
132.84
111.19
93.07
194.08
86.25
61.49
70.78
59.81
110.08
130.41
166.27
Net Sales Growth
25.71%
19.47%
-52.05%
125.02%
40.27%
-13.13%
18.34%
-45.67%
-15.59%
-21.57%
 
Cost Of Goods Sold
54.48
44.85
37.55
52.97
37.97
35.79
39.25
29.38
53.85
70.43
90.74
Gross Profit
78.36
66.34
55.52
141.11
48.28
25.70
31.54
30.43
56.23
59.98
75.53
GP Margin
58.99%
59.66%
59.65%
72.71%
55.98%
41.80%
44.56%
50.88%
51.08%
45.99%
45.43%
Total Expenditure
116.95
95.48
76.23
92.94
66.57
65.16
72.68
63.36
87.31
110.25
137.62
Power & Fuel Cost
-
3.93
3.60
3.92
2.94
2.56
2.28
1.86
1.90
1.39
2.06
% Of Sales
-
3.53%
3.87%
2.02%
3.41%
4.16%
3.22%
3.11%
1.73%
1.07%
1.24%
Employee Cost
-
26.77
18.61
18.06
14.57
13.86
14.69
16.98
17.24
14.71
17.26
% Of Sales
-
24.08%
20.00%
9.31%
16.89%
22.54%
20.75%
28.39%
15.66%
11.28%
10.38%
Manufacturing Exp.
-
4.52
5.09
4.20
3.00
1.73
1.32
1.06
1.20
1.24
1.93
% Of Sales
-
4.07%
5.47%
2.16%
3.48%
2.81%
1.86%
1.77%
1.09%
0.95%
1.16%
General & Admin Exp.
-
9.39
7.89
6.29
4.31
5.70
5.91
5.81
5.96
6.62
7.42
% Of Sales
-
8.45%
8.48%
3.24%
5.00%
9.27%
8.35%
9.71%
5.41%
5.08%
4.46%
Selling & Distn. Exp.
-
4.70
2.59
5.75
2.65
2.27
5.17
2.95
0.37
8.61
13.20
% Of Sales
-
4.23%
2.78%
2.96%
3.07%
3.69%
7.30%
4.93%
0.34%
6.60%
7.94%
Miscellaneous Exp.
-
1.33
0.90
1.74
1.14
3.24
4.07
5.31
6.80
7.25
13.20
% Of Sales
-
1.20%
0.97%
0.90%
1.32%
5.27%
5.75%
8.88%
6.18%
5.56%
3.01%
EBITDA
15.88
15.71
16.84
101.14
19.68
-3.67
-1.90
-3.55
22.77
20.16
28.65
EBITDA Margin
11.95%
14.13%
18.09%
52.11%
22.82%
-5.97%
-2.68%
-5.94%
20.68%
15.46%
17.23%
Other Income
1.71
1.45
3.40
2.09
1.56
3.09
2.09
2.13
2.24
2.06
2.35
Interest
2.87
4.89
11.87
20.13
25.94
20.07
7.17
9.58
18.72
16.42
25.57
Depreciation
8.25
12.80
14.15
17.35
8.32
8.01
7.31
11.28
10.25
9.32
10.87
PBT
6.47
-0.52
-5.78
65.77
-13.02
-28.66
-14.29
-22.28
-3.97
-3.52
-5.44
Tax
2.66
1.69
-0.02
20.80
-4.05
0.74
-9.07
-1.04
-1.51
-0.19
1.06
Tax Rate
41.11%
-181.72%
0.15%
35.11%
28.62%
-1.20%
58.78%
5.19%
18.62%
-4.86%
-28.96%
PAT
3.82
-2.49
-13.21
39.00
-11.55
-60.54
-5.55
-17.21
-5.54
3.69
-4.95
PAT before Minority Interest
4.12
-2.62
-13.15
38.44
-10.09
-62.62
-6.35
-19.00
-6.60
4.09
-4.72
Minority Interest
0.30
0.13
-0.06
0.56
-1.46
2.08
0.80
1.79
1.06
-0.40
-0.23
PAT Margin
2.88%
-2.24%
-14.19%
20.09%
-13.39%
-98.46%
-7.84%
-28.77%
-5.03%
2.83%
-2.98%
PAT Growth
207.91%
-
-
-
-
-
-
-
-
-
 
EPS
1.07
-0.70
-3.70
10.92
-3.24
-16.96
-1.55
-4.82
-1.55
1.03
-1.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Shareholder's Funds
68.15
45.44
13.34
-25.80
-14.34
43.02
49.47
37.71
45.24
43.06
Share Capital
33.09
30.69
28.69
28.69
28.69
28.14
28.14
22.04
23.13
22.67
Total Reserves
26.00
-2.69
-15.35
-54.49
-43.03
14.12
20.57
15.67
22.11
20.07
Non-Current Liabilities
50.82
73.25
72.77
148.88
136.67
72.28
5.28
38.68
28.52
36.95
Secured Loans
7.18
0.39
0.86
150.65
125.45
78.39
4.06
34.93
25.31
28.92
Unsecured Loans
35.73
63.40
61.63
0.71
0.64
0.90
0.87
0.84
0.00
0.00
Long Term Provisions
1.82
2.44
3.47
3.66
3.86
4.08
3.63
4.39
2.92
4.30
Current Liabilities
37.64
32.60
99.35
49.88
66.32
84.81
167.12
165.45
162.83
195.24
Trade Payables
12.10
9.41
12.00
14.71
18.85
23.23
24.21
39.16
42.08
54.64
Other Current Liabilities
12.41
14.35
66.24
23.10
30.83
43.31
92.38
73.07
56.55
79.41
Short Term Borrowings
11.61
7.64
20.07
10.37
14.41
16.26
45.82
50.23
59.95
59.85
Short Term Provisions
1.52
1.20
1.05
1.70
2.23
2.02
4.72
2.99
4.26
1.35
Total Liabilities
156.72
151.52
185.61
173.66
187.88
202.85
225.23
248.87
240.50
278.76
Net Block
57.70
68.10
93.96
98.19
104.78
107.73
116.04
132.90
104.23
121.64
Gross Block
160.37
157.96
177.35
202.50
188.36
202.81
155.31
144.01
200.41
213.51
Accumulated Depreciation
102.67
89.87
83.40
104.31
83.58
95.08
39.27
11.11
96.18
91.87
Non Current Assets
106.07
107.32
133.42
144.59
152.00
167.75
176.16
186.07
158.70
177.08
Capital Work in Progress
23.05
16.23
17.74
25.76
27.76
31.07
27.88
24.23
30.17
27.03
Non Current Investment
0.07
0.04
0.01
0.01
0.01
0.01
0.23
0.26
0.39
0.32
Long Term Loans & Adv.
25.25
22.96
21.71
20.63
19.46
28.94
32.01
28.69
23.92
28.09
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
50.65
44.20
52.20
29.08
35.88
35.11
49.07
62.79
81.81
101.69
Current Investments
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
Inventories
9.57
6.95
8.20
4.31
6.73
7.00
11.20
13.24
10.81
19.25
Sundry Debtors
26.99
20.13
18.45
8.67
8.04
14.63
20.50
29.17
43.29
56.70
Cash & Bank
5.95
11.71
17.05
7.15
10.30
1.71
2.43
5.12
5.56
6.51
Other Current Assets
8.12
2.93
2.87
4.73
10.80
11.77
14.95
15.25
22.14
19.23
Short Term Loans & Adv.
4.78
2.48
5.62
4.21
4.26
9.64
13.21
10.92
17.22
14.57
Net Current Assets
13.01
11.61
-47.15
-20.80
-30.44
-49.70
-118.05
-102.66
-81.03
-93.55
Total Assets
156.72
151.52
185.62
173.67
187.88
202.86
225.23
248.86
240.51
278.77

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Cash From Operating Activity
1.77
8.95
79.25
8.81
5.32
26.67
10.88
31.38
11.95
26.54
PBT
-0.93
-13.17
59.25
-14.14
-61.88
-15.42
-20.04
-8.10
3.69
-4.95
Adjustment
18.02
31.78
41.93
35.40
55.76
15.17
20.79
30.53
16.15
31.64
Changes in Working Capital
-13.80
-9.86
-21.01
-11.64
10.94
27.65
10.36
10.10
-7.57
-0.79
Cash after chg. in Working capital
3.29
8.75
80.16
9.62
4.82
27.39
11.10
32.53
12.27
25.90
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.52
0.20
-0.92
-0.81
0.50
-1.10
-0.44
-1.20
-0.33
-0.10
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.37
0.23
0.06
0.00
0.74
Cash From Investing Activity
-9.49
7.35
-6.17
-0.16
-0.11
-3.97
-3.17
-12.67
17.29
28.99
Net Fixed Assets
-9.23
19.80
-2.28
-20.42
-43.81
-2.41
-3.63
12.94
-4.69
29.40
Net Investments
-0.01
0.00
0.00
0.00
30.05
-0.01
0.00
0.12
0.00
-0.04
Others
-0.25
-12.45
-3.89
20.26
13.65
-1.55
0.46
-25.73
21.98
-0.37
Cash from Financing Activity
1.95
-21.64
-63.18
-11.80
3.38
-23.42
-10.41
-19.15
-30.19
-59.72
Net Cash Inflow / Outflow
-5.76
-5.34
9.90
-3.15
8.60
-0.72
-2.69
-0.43
-0.96
-4.20
Opening Cash & Equivalents
11.71
17.05
7.15
10.30
1.71
2.43
5.12
5.56
6.51
10.71
Closing Cash & Equivalent
5.95
11.71
17.05
7.15
10.30
1.70
2.43
5.12
5.56
6.51

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Book Value (Rs.)
17.86
9.12
4.65
-8.99
-5.00
15.02
16.78
15.82
16.94
14.99
ROA
-1.70%
-7.80%
21.40%
-5.58%
-32.05%
-2.97%
-8.02%
-2.70%
1.58%
-1.55%
ROE
-6.02%
-63.63%
0.00%
0.00%
-448.65%
-14.20%
-46.30%
-18.27%
11.74%
-13.05%
ROCE
3.26%
-1.00%
56.68%
8.95%
-31.39%
-5.50%
-6.52%
6.66%
12.41%
11.73%
Fixed Asset Turnover
0.70
0.56
1.02
0.44
0.31
0.40
0.41
0.68
0.65
0.75
Receivable days
77.33
75.65
25.51
35.37
67.29
90.56
149.54
113.31
136.29
132.10
Inventory Days
27.12
29.71
11.76
23.36
40.77
46.92
73.58
37.61
40.97
37.15
Payable days
87.52
104.00
92.01
161.35
117.58
127.84
181.43
174.53
168.94
158.77
Cash Conversion Cycle
16.94
1.36
-54.74
-102.62
-9.53
9.65
41.69
-23.60
8.32
10.48
Total Debt/Equity
0.96
2.58
9.76
-6.30
-9.85
2.28
2.39
3.60
3.12
4.05
Interest Cover
0.81
-0.11
3.94
0.45
-2.08
-1.15
-1.09
0.57
1.24
0.86

News Update:


  • Lyka Labs - Quarterly Results
    4th Feb 2025, 15:11 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.